Form 4: Molina Healthcare Director Acquires 285 Shares

Molina Healthcare Director Dale B. Wolf acquired 285 shares of common stock valued at $192.79 per share as part of a routine equity incentive plan.

Summary

• Director Dale B. Wolf acquired 285 shares of Molina Healthcare, Inc. common stock.
• The transaction occurred on October 1, 2025, at a price of $192.79 per share.
• This acquisition was a grant under the Issuer's 2025 Equity Incentive Plan, related to services as a Director.
• The annual equity award for directors is $220,000, with $55,000 granted quarterly.
• Following this transaction, Dale B. Wolf beneficially owns 14,674 shares, held indirectly by the Dale B. Wolf Revocable Trust.

Sentiment

Score: 6

Explanation: The filing reports a routine, expected stock grant to a director as part of their compensation plan, which is a neutral to slightly positive event indicating ongoing director involvement and alignment with shareholder interests.

Positives

• Director Dale B. Wolf increased their beneficial ownership in Molina Healthcare by 285 shares, demonstrating continued alignment with shareholder interests.
• The grant is part of a structured 2025 Equity Incentive Plan, indicating a clear compensation strategy for directors.

Negatives

• No specific negative aspects are identified in this routine Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This routine insider transaction, a director's stock grant, does not provide specific insights into broader industry trends or competitive landscape. It reflects standard corporate governance practices for director compensation within the healthcare sector.

Comparison to Industry Standards

• The filing does not provide sufficient information for a detailed comparison to global benchmarks or specific comparable companies/projects. Director equity compensation plans are common across industries, and the specific value of $220,000 annually ($55,000 quarterly) would need to be benchmarked against similar-sized healthcare companies to assess its competitiveness.

Corporate Governance

Related Party Transactions

• Director Dale B. Wolf received 285 shares of common stock as compensation under the company's 2025 Equity Incentive Plan, which is a transaction between the company and a related party (a director).

Stakeholder Impact

• **Shareholders**: Increased alignment of a director's interests with shareholders through equity ownership.
• **Employees**: No direct impact mentioned.
• **Customers**: No direct impact mentioned.
• **Suppliers**: No direct impact mentioned.
• **Creditors**: No direct impact mentioned.

Next Steps

• The filing does not mention any specific future actions, events, or milestones beyond the routine nature of the quarterly grants.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled stock grant to a director as part of their compensation. Such a transaction is generally expected and does not typically provide new material information that would warrant a change in investment recommendation. It reflects ongoing corporate governance and director alignment but does not indicate a significant shift in the company's fundamentals or outlook.

Keywords

Molina Healthcare, MOH, Director Stock Acquisition, Equity Incentive Plan, Insider Trading, Form 4, Dale B. Wolf, Common Stock